Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Rulemaking document · As of Sep 23, 2026

Rulemaking document

Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Sep 23, 2026.

Document type: Notice
Subtype: Withdrawal
Title: Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets
Fr doc num: 2026-16536
Posted date: 2026-08-13T04:00:00+00:00
Comment start date: 2026-08-13T04:00:00+00:00
Comment end date: 2026-10-14T03:59:59+00:00
Last modified date: 2026-09-19T11:46:00+00:00
Within comment period: true
Open for comment: true
Withdrawn: false
Ingested at: 2026-09-23T23:13:21.504074+00:00

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets

Rulemaking document	What this connects to	Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets has a recorded connection to Rulemaking document.	None